Federal Register / Vol. 73, No. 172 / Thursday, September 4, 2008 / Notices 51649 

October 23, 2008, and shortly thereafter 

will issue a public version of the report 

with any confidential business 

information deleted. Additional 

information concerning the articles and 

the proposed modifications can be 

obtained by accessing the electronic 

version of this investigation and the 

USTR request letter at the Commission 

Internet site (http://www.usitc.gov). The 

current USAFTA rules of origin 

applicable to U.S. imports can be found 

in general note 28 of the 2008 HTS (see 

General Notes link at http:// 

www.usitc.gov/tata/hts/bychapter/ 

index.htm). The HTS subheading 

affected is 5510.90. All other 

subheadings covered by the current 

rules of origin would experience no 

change. 

Written Submissions: No public 

hearing is planned. However, interested 

parties are invited to submit written 

statements concerning this 

investigation. All written submissions 

should be addressed to the Secretary, 

and should be received not later than 

5:15 p.m., September 17, 2008. All 

written submissions must conform to 

the provisions of section 201.8 of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.8). Section 201.8 

requires that a signed original (or a copy 

so designated) and fourteen (14) copies 

of each document be filed. In the event 

that confidential treatment of a 

document is requested, at least four (4) 

additional copies must be filed, in 

which the confidential information 

must be deleted (see the following 

paragraph for further information 

regarding confidential business 

information). The Commission’s rules 

authorize filing submissions with the 

Secretary by facsimile or electronic 

means only to the extent permitted by 

section 201.8 of the rules (see Handbook 

for Electronic Filing Procedures, http:// 

www.usitc.gov/secretary/ 

fed_reg_notices/rules/documents/ 

handbook_on_electronic_filing.pdf). 

Persons with questions regarding 

electronic filing should contact the 

Secretary (202–205–2000). 

Any submissions that contain 

confidential business information must 

also conform to the requirements of 

section 201.6 of the Commission’s Rules 

of Practice and Procedure (19 CFR 

201.6). Section 201.6 of the rules 

requires that the cover of the document 

and the individual pages be clearly 

marked as to whether they are the 

confidential or non-confidential version, 

and that the confidential business 

information is clearly identified by 

means of brackets. All written 

submissions, except for confidential 

business information, will be made 

available for inspection by interested 

parties. 

The Commission may include some or 

all of the confidential business 

information submitted in the course of 

this investigation in the report it sends 

to the USTR and the President. As 

requested by the USTR, the Commission 

will publish a public version of the 

report. However, in the public version, 

the Commission will not publish 

confidential business information in a 

manner that would reveal the operations 

of the firm supplying the information. 

Issued: August 28, 2008. 

By order of the Commission. 

Marilyn R. Abbott, 

Secretary to the Commission. 

[FR Doc. E8–20495 Filed 9–3–08; 8:45 am] 

BILLING CODE 7020–02–P 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes: Call for Nominations 

AGENCY: U.S. Nuclear Regulatory 

Commission. 

ACTION: Call for Nominations. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) is advertising for 

nominations for three upcoming 

vacancies on NRC’s Advisory 

Committee on the Medical Uses of 

Isotopes (ACMUI): radiation oncologist 

with experience in gamma stereotactic 

radiosurgery, nuclear medicine 

physicist, and radiation safety officer. 

DATES: Nominations are due on or 

before November 3, 2008. 

Nomination Process: Submit an 

electronic copy of resume or curriculum 

vitae to Ms. Ashley Tull, 

ashley.tull@nrc.gov. Please ensure that 

resume or curriculum vitae includes the 

following information, if applicable: 

Education; certification; professional 

association membership and committee 

membership activities; duties and 

responsibilities in current and previous 

clinical, research, and/or academic 

position(s). 

FOR FURTHER INFORMATION CONTACT: Ms. 

Ashley Tull, U.S. Nuclear Regulatory 

Commission, Office of Federal and State 

Materials and Environmental 

Management Programs; (240) 888–7129; 

ashley.tull@nrc.gov. 

SUPPLEMENTARY INFORMATION: The 

ACMUI advises NRC on policy and 

technical issues that arise in the 

regulation of the medical use of 

byproduct material. Responsibilities 

include providing comments on changes 

to NRC rules, regulations, and guidance 

documents; evaluating certain nonroutine uses of byproduct material; 

providing technical assistance in 

licensing and inspections; and bringing 

key issues to the attention of NRC, for 

appropriate action. 

ACMUI members possess the medical 

and technical skills needed to address 

evolving issues. The current 

membership is comprised of the 

following professionals: (a) Nuclear 

medicine physician; (b) nuclear 

cardiologist; (c) nuclear medicine 

physicist; (d) therapy medical physicist; 

(e) radiation safety officer; (f) nuclear 

pharmacist; (g) two radiation 

oncologists; (h) patients’ rights 

advocate; (i) Food and Drug 

Administration representative; (j) 

Agreement State representative; and (k) 

health care administrator. 

NRC is inviting nominations for the 

nuclear medicine physicist, radiation 

oncologist, and radiation safety officer 

appointments to the ACMUI. The term 

of the individuals currently occupying 

these positions will end May 19, 2009, 

September 30, 2009 and September 30, 

2009, respectively. Committee members 

currently serve a four-year term and 

may be considered for reappointment to 

an additional term. 

Nominees must be U.S. citizens and 

be able to devote approximately 160 

hours per year to Committee business. 

Members who are not Federal 

employees are compensated for their 

service. In addition, members are 

reimbursed travel (including per-diem 

in lieu of subsistence) and are 

reimbursed secretarial and 

correspondence expenses. Full-time 

Federal employees are reimbursed travel 

expenses only. 

Security Background Check: The 

selected nominee will undergo a 

thorough security background check. 

Security paperwork may take the 

nominee several weeks to complete. 

Nominees will also be required to 

complete a financial disclosure 

statement to avoid conflicts of interest. 

Dated at Rockville, Maryland this 28th day 

of August 2008. 

For the U.S. Nuclear Regulatory 

Commission. 

Andrew L. Bates, 

Advisory Committee Management Officer. 

[FR Doc. E8–20477 Filed 9–3–08; 8:45 am] 

BILLING CODE 7590–01–P 


sroberts on PROD1PC77 with NOTICES